Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Harmony Biosciences Holdings, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/31/2023 |
4/A
| Dayno Jeffrey M. (PRESIDENT, CEO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 125,000 options
@ $0 |
|
| 09/04/2020 |
4/A
| Marshman Fund Trust II (10% Owner) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Converted 3,379,881 shares
@ $0
Converted 25,000,000 preferred shares
@ $0 |
|
| 09/04/2020 |
4/A
| Serafin Andrew (Chief Business Officer) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Converted 33,693 shares
@ $0
Converted 200,000 preferred shares
@ $0
Converted 51,021 preferred shares
@ $0 |
|
| 09/04/2020 |
4/A
| Valor IV Pharma Holdings, LLC (10% Owner) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Converted 10,139,645 shares
@ $0
Converted 233,052 shares
@ $0
Converted 75,000,000 preferred shares
@ $0
Converted 1,786,985 preferred shares
@ $0 |
|
| 09/04/2020 |
4/A
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Converted 3,622,470 shares
@ $0
Converted 25,000,000 convertible preferred
@ $0
Converted 1,860,107 convertible preferred
@ $0 |
|
|
|